No Data
No Data
J.P. Morgan Maintains Ardent Health Partners(ARDT.US) With Hold Rating, Cuts Target Price to $18
Express News | Ardent Health Partners Inc : JP Morgan Cuts Target Price to $18 From $20
BofA Securities Maintains Ardent Health Partners(ARDT.US) With Hold Rating, Maintains Target Price $17
Ardent Health Partners, Inc.: Balancing Growth Opportunities and Financial Risks With a Hold Rating
Truist Financial Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Announces Target Price $21
Leerink Partners Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Cuts Target Price to $21